Assay News and Research

RSS
Chronix Biomedical expands biomarker development capabilities with installation of DNA mass sequencer

Chronix Biomedical expands biomarker development capabilities with installation of DNA mass sequencer

Intercell reports significant increase in second quarter revenue

Intercell reports significant increase in second quarter revenue

IVAX Diagnostics second quarter 2010 operating expenses decrease 11.9%

IVAX Diagnostics second quarter 2010 operating expenses decrease 11.9%

Alverix and BD partner to develop point of care infectious disease diagnostic assay systems

Alverix and BD partner to develop point of care infectious disease diagnostic assay systems

Clearstone Central Laboratories announces strategic global collaboration with LabCorp

Clearstone Central Laboratories announces strategic global collaboration with LabCorp

Problems with analytical study design and data misinterpretation leads to biomarker failure: Report

Problems with analytical study design and data misinterpretation leads to biomarker failure: Report

Transgenomic second-quarter net loss increases to $1.1 million

Transgenomic second-quarter net loss increases to $1.1 million

Amorfix first-quarter fiscal 2011 net loss from operations increases to $1,724,745

Amorfix first-quarter fiscal 2011 net loss from operations increases to $1,724,745

Scientists develop new metabolite analysis technique for accurate ovarian cancer detection

Scientists develop new metabolite analysis technique for accurate ovarian cancer detection

ACD launches RNAscope Formalin-Fixed, Paraffin-Embedded Assay Kit

ACD launches RNAscope Formalin-Fixed, Paraffin-Embedded Assay Kit

Nanosphere reports net loss of $13.8M for second-quarter 2010

Nanosphere reports net loss of $13.8M for second-quarter 2010

WaferGen launches SmartChip System for discovery, validation of biomarkers

WaferGen launches SmartChip System for discovery, validation of biomarkers

SeraCare optimizes ACCURUN 341 Nucleic Acid Positive controls

SeraCare optimizes ACCURUN 341 Nucleic Acid Positive controls

AMRI second-quarter adjusted EPS increases to $0.06

AMRI second-quarter adjusted EPS increases to $0.06

IL releases new HemosIL HIT-Ab(PF4-H) assay

IL releases new HemosIL HIT-Ab(PF4-H) assay

Life Technologies launches new assay to detect deadly strain of E. coli

Life Technologies launches new assay to detect deadly strain of E. coli

Almac's solutions to support biopharma companies by adopting biomarker strategies

Almac's solutions to support biopharma companies by adopting biomarker strategies

Gen-Probe second-quarter 2010 product sales up 14%

Gen-Probe second-quarter 2010 product sales up 14%

AdvanDx's 90 minutes protocol for Yeast Traffic Light PNA FISH test receives FDA 510(k) clearance

AdvanDx's 90 minutes protocol for Yeast Traffic Light PNA FISH test receives FDA 510(k) clearance

Researchers develop new fluorescent biosensor for drug development

Researchers develop new fluorescent biosensor for drug development

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.